CLINICAL_TRIALS
trial_result
· 2025-06-04
Clinical Trial Update: Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults [Phase 1]
Summary
A Phase 1 trial update reports on safety, tolerability, and pharmacokinetics assessment of the TB drug candidate TBAJ-876 in healthy adults, with the study comp…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Global Alliance for TB Drug Development | Conditions: Pulmonary Disease, Tuberculosis, Pulmonary | Phase 1 | Status: COMPLETED